Single Ascending Dose Study Investigating the Safety, Tolerability, and PK of XC130-A10H in Healthy Adult Subjects

Clinical trial NCT04043338 · UNKNOWN

Trial details

NCT number: NCT04043338
Sponsor: Xoc Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease

Start date: 2019-08-11
Primary completion: 2022-01-30
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.